Sheila A. Denton, the EVP & General Counsel of $INCY, sold 278 shares of the company on 09-16-2025 for an estimated $23,115. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 33,200 shares of this class of $INCY stock.
$INCY Insider Trading Activity
$INCY insiders have traded $INCY stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $INCY stock by insiders over the last 6 months:
- STEVEN H STEIN (EVP & Chief Medical Officer) has made 0 purchases and 2 sales selling 18,658 shares for an estimated $1,275,549.
- BARRY P FLANNELLY (EVP & General Manager US) has made 0 purchases and 3 sales selling 13,435 shares for an estimated $917,914.
- VIJAY K IYENGAR (EVP, GMAPPS) has made 0 purchases and 4 sales selling 10,777 shares for an estimated $736,698.
- SHEILA A. DENTON (EVP & General Counsel) has made 0 purchases and 8 sales selling 8,260 shares for an estimated $592,738.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$INCY Hedge Fund Activity
We have seen 347 institutional investors add shares of $INCY stock to their portfolio, and 364 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,390,084 shares (+701.8%) to their portfolio in Q2 2025, for an estimated $162,764,720
- AQR CAPITAL MANAGEMENT LLC added 1,465,286 shares (+21.8%) to their portfolio in Q2 2025, for an estimated $99,785,976
- MARSHALL WACE, LLP added 1,211,231 shares (+inf%) to their portfolio in Q2 2025, for an estimated $82,484,831
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. added 995,204 shares (+71.5%) to their portfolio in Q2 2025, for an estimated $67,773,392
- SG AMERICAS SECURITIES, LLC added 910,044 shares (+2325.7%) to their portfolio in Q2 2025, for an estimated $61,973,996
- HSBC HOLDINGS PLC removed 678,906 shares (-64.8%) from their portfolio in Q2 2025, for an estimated $46,233,498
- POINT72 ASSET MANAGEMENT, L.P. added 643,069 shares (+188.0%) to their portfolio in Q2 2025, for an estimated $43,792,998
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$INCY Congressional Stock Trading
Members of Congress have traded $INCY stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $INCY stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$INCY Analyst Ratings
Wall Street analysts have issued reports on $INCY in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 09/04/2025
- BMO Capital issued a "Underperform" rating on 07/30/2025
- Citigroup issued a "Buy" rating on 07/30/2025
- Stifel issued a "Buy" rating on 06/16/2025
To track analyst ratings and price targets for $INCY, check out Quiver Quantitative's $INCY forecast page.
$INCY Price Targets
Multiple analysts have issued price targets for $INCY recently. We have seen 12 analysts offer price targets for $INCY in the last 6 months, with a median target of $76.0.
Here are some recent targets:
- Tazeen Ahmad from B of A Securities set a target price of $104.0 on 09/04/2025
- Jessica Fye from JP Morgan set a target price of $73.0 on 08/22/2025
- Derek Archila from Wells Fargo set a target price of $89.0 on 08/06/2025
- Luke Sergott from Barclays set a target price of $90.0 on 08/01/2025
- David Lebowitz from Citigroup set a target price of $103.0 on 07/30/2025
- Brian Abrahams from RBC Capital set a target price of $72.0 on 07/30/2025
- Nicholas Holowko from UBS set a target price of $68.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
